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[n ea rl ier studies, it was shown that the hum an plas ma-
spre"ding glycoprotein , epibolin (the 65 kD species of serum-
spreadin g factor or vitronectin), requires a second plasma 
co mponent, termed coepibolin , in order to support max-
ima l dissociated ep idermal cell spread ing in ti ssue cu lture. 
Whereas ep ibolin alone in defined medium supports some 
cell spreading, the purified plasma coepibolin preparations 
do not effect spreading in the absence ofepibo lin . Although 
not yet entirely pu ri fied, coepibo lin associates with so me 
plasma fractions but not with others; it is certainly no t a 
property of all proteins, e.g., w hile bovine serum albumin 
(BSA) has coepibo lin acti vity, ovalbumin does not. T he 
data presented here show that the ph o rbol es ter, 12-tetra-
decanoy l-l -phorbol-13-acetate (TPA) can act as a potent 
E pibolin is a 65-kD g lycoprotein isolated from hum an plasm a w hi ch s. upports the spread ing of epidermal Cel.IS in culture 11,2 1. Recent work suggests that ep ibo lin is chem ica ll y and immuno logica ll y similar to prepara-. tions put forth by other laborator ies and referred to as 
alpha protein growth factor (AGF) IJ,4], as serum-sp read in g fac-
tor [51. as v itronecti n [6] in the hum an system, and as 70 kD 
factor 17,8] in the bovine system. Specifi ca ll y, it appears to be 
the 65 kD species of serum-sp read in g factor (Stenn , in prepara-
tion). 
In itia l studies [11 of epibolin showed that a cofactor, a second 
plasma fract ion referred to as coep ibolin , was needed in o rder to 
effect maxima l prim ary epidermal cell spread ing in vitro . 
In a study of the effect of various agents on th e spreading of 
epiderm al cell s in vitro, we observed that the phorbol ester, 12-
tetradecanoy lphorbol-13-acetate (TPA), can serve as a potent co-
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Abbreviations : 
BSA: bovinc se rum album in 
I MEM: Du.lbecco·s modifi ed Eagle's medium 
IBMX : 3-isobutyl- l-rn ethylxanthinc 
OAG: 1-0Icoyl-2-acc tyl-sn-glyce ro l 
PDD: phorbol-12, 13-didecanoate 
4aPDD: 4-a lpha-pho rbo l-12,13-didecanoate 
TPA: 12-tetradecanoylphorbol- 13-aceta tc 
coepiboli n and support max ima l spreading over a concen-
tration range of 10-100 ng / ml. In the absence of ep ibolin 
TPA does not stimulate the spreadin g of epiderm al cells 
when given alone o r in the presence ofBSA or ovalbumin . 
Coepibolin activity appea rs to associate with tumo r-p ro-
mo tin g activity in that the phorbol derivative, phorbol-
12,13-didecanoate, shows coepibolin activity , w hile its in-
active non-wmor-promoting isom er, pho rbol-411'-phor-
bol-12,13-didecanoate, does not . T hese data suggest that 
the protein aceous plasma-derived cofacto r acts in a fash ion 
similar to T PA and that this as yet unex plained mechanism 
ofTPA action is important to the full express ion of epibolin 
and to the ea rl y phase of epidermal cell sp readin g. J fl lllest 
Derma/ol 87:754-757, 1986 
epibolin . Reported here arc stud ies doculllenting that effect and 
implicating the importance of this as yet unelucidated mechanism 
in the ea rl y phases of epidermal cell spread in g . 
MATE RIALS AND METHODS 
General All chemicals used we re of reagent g rade purchased 
from loca l suppliers. Water was sin gly d istilled . Bovine serum 
albumin (BSA A4503, Fraction V) , ova lbumin, trypsi n, soybean 
trypsin inhibi tor, 3-isobutyl-l-methylxanthine (IB M X) , and TPA 
were purchased from Sigma C hem ical Company (St. Louis, Mis-
souri). Phorbol-12,13-didecanoate (PDD), 4--a lpha-phorbol-12,13-
didecanoate (4a PDD) , and m ezerein were from L. C. Services 
Corp. (Woburn. Massachuset ts), and 1-0Ieoyl-2-acety l-sn-g lyc-
ero l (OAG) fr'om Sigma C hemi ca l Co. and Avanti Po lar Lipids, 
Inc. (Birmin gham , Alabama). 1-O leoyl-2-acetyl-sn-glycerol from 
the latte r was received in chlo rofo rm in dry icc and , accordin g 
to the manu fac turer's in st ru ct ions, it was dried un der N 2, d is-
solved for use in DMSO, and soni ca ted in the test m ed ium im-
med iately befo re usc. Dulbecco's mod ified Eagle's med ium 
(D MEM) was obta ined fro Ill G ibco (Grand Island , N ew York). 
Protein Purification Protei n concentrat io n was measured by 
the method of Lowry et al 19]. Epi bolin was prepared as previ-
ously described from blood bank hum an plas ma ll], but was used 
after step 3 by washing the protei n fract ion bound to a co lumn 
of heparin-sepharose (B iolbd, 2 X 2 cm) with a solu tion of 50 
mM N a2H / N al-clzP04, pH 7.2, p lus 100 mM N aCluntil the ab-
so rban ce at 280 nl11 (A 2HU) was less than 0.05. T he active protein 
was eluted stepwise w ith 50 mM N aH2/ Na2HPO,,, pH 7.2, plus 
500 mM N aCI. T his preparation is no t pure but contains a prol11-
in ent band at M , (i5 kD (sod ium dodecy l sulfate-polyacrylamide 
gel electropho res is (SDS-PAGE) performed as prev iously II J) and 
its sp!'eading activity is co mpletely blocked by a 111 0noclonal an-
tibody to epibolin (Stenn et ai, in preparation). 
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Cell-Spreading Assay Dissociated guinea pi g epidermal cell-
spre adin g activity was assayed as previously described \1 ,21. BrieRy, 
epidermis was removed from thin sheets of skin by trypsini zation. 
Epide rm al cell s we re di ssocia ted by min cing the epidermis with 
crossed sca lpel blades and trituratin g the fra g ments in Tyrode's 
soJuti on plus soybea n trypsin inhibito r (0 .1 mg/ml ). The cell s 
were rin sed once in DMEM and used immediately for the assay 
by adding 1 x 105 cells per 34 X 10 I1lm ti ssue culture Petri dish 
(Co rnin g) . The cells were added to culture dis hes containin g 2 
mJ of DMEM plus the various additio ns described under Resllits. 
Afte r 4-h in cubation at 37"C (95% air , 5% CO2, 100% l-hO) , 
th e spread cells were fi xed , stained in Giemsa, and quantitated 
mic roscopica ll y. Coep ibo lin was assayed by usin g a limiting con-
centration (1-2 J,tg/mi) of epibolin in o rd er to ma ximize the sen-
sitivity o f the assay for coe pibo lin activity. The results arc ex-
pressed as the number of cell s spread per 100 cells attached. Unless 
otherwise indi cated, each experim ental po int represents the av-
e r age percent of spread cells from at leas t 2 experiments counting 
over 600 cells. In this assay, 5-10% serum suppo rts a m ax imal 
spreading of 50-70% of the ad herent cells by 4 h . 
RESULTS 
Coepibolin Activity of Serum Albumin and Ovalbumin 
Ea d y studies [1] had indi ca ted that ep ibo lin alone did not produce 
m ax imal spreadin g of fresh guin ea pig epidermal cells. In contrast, 
the additio n of crude, inactive plasma fra ction to th e purified 
epibo lin preparation led to maximal epidermal cell spreading . 
B ecau se that fraction alone was in ac ti ve in the spreadin g assays 
and because it appeared to enh ance the ac ti vity of epibolin , its 
acti vity was referred to as coepibolin. As shown in Fi g 1, at least 
one coepibolin in plasma is associated with albumin. In the pres-
en c e of ep ibo lin alo ne o r epibolin plus ova lbumin there was less 
than maxima l spread in g (1 0-30%), w hile m axim al spreadin g oc-
curred in the presence o f epibo lin plus albumin (50-65% ). These 
data indi ca te th at epibolin alone supports subm aximal spreadin g 
of e pidermal cells and th at this activity is enhanced about 3 tim es 
b y a lbumin. The coepibolin activity of albumin is no t a nonspe-
cift c protein effect beca use other proteins (S tenn, submitted for 
publica tion) in add ition to ova lbumin are in ac tive . 
Coepibolin Activity of TPA In a preliminary study on the 
effect of a series of rea gents on epibo lin-induced cell spreading, 
we observed th at serum albumin o r plasma-deri ved coepibolin 
(not shown here) ca n be entirely substituted by the pho rbol ester, 
80 
Figure 1. Coepibolin activity of serum album in and ova lbulllin with 
va rying concentrations of epibolin. Epidermal cel l spreading in the pres-
en ce of epibolin plus no protein addition (6 -6) , ovalbumin (x-x , I mg/ml), 
or BSA (e-e, 1 mg/ ml). Bnl's , SE. 
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Figure 2. Hate of cell spread ing with different coepibolin preparations. 
Ex tcnt of cpiderm al cell spreading with time in mcci ia containing cpibolin 
(2.5 ILg/ ll1l ) and no addition (e_e). \3SA (I mg/ ml , 0 -0 ). or T I'A (10 
ng/ml, 6-6) . Bnr" SE. 
TPA. In contrast, TPA co uld no t replace epiboIin (Figs 2-4). In 
Fig 2 arc data showing that o ver a 4-h period epibo lin alone ca Ll ses 
some cell spreadin g, but it is less than that occu rrin g after the 
additi on of a coepibo lin (here BSA) . 12-Tetradecanoylphorbol-
13-acetate ca n replace BSA entirel y. All 3 experim ents show es-
sentiall y th e sa m e rate of attainin g the m ax ima l spread ing level. 
Figure 3 shows that TPA alone over a w ide co ncentration ran ge 
(0.05-200 ng / ml) does no t support cell spread in g . In order to 
support spreading TPA requires epibolin ; it docs not replace epi-
bohn and thus it alone is no t suffi cient fo r spreading . In the 
presence of cp ibolin, m ax imal sp readin g was o bserved at a TP A 
concentration as low as 1.0 ng/ ml. There w as no spread ing in 
the presence of TPA and either BSA o r ova lbul1lin (Fig 4) over 
the sam e concentration ran ge . 
Coepibolin Activity of Diacylglycerol and Other Related 
Derivatives A series o f TPA-rel ated agents was tes ted for co-
epibo Iin activity (Table I). T he test chemicals were added to the 
cul ture med ia containing a lim iting concentratio n of epiboIin (1-2 
/-Lg/ml) in th e presence o r absence ofTP A. When the diacylg ly-
ce ro l, OAG , was used at concentrations kn own to stimul ate pro-
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Figure 3 . . Spread ing activity of va rioLl S proteins over a range of T PA 
concentrations. VarYing TPA concentration from 0-200 ng/ml. cell 
spr.eadlllg was quantitated m the presence of the fo llow ing protein ad-
ditions: BSA (e-e, I mg/ml ), ova lbu111111 (x-x, 1 I11 g/ ml), cpibolin (0 -0, 
2.5 ILg/ ml) and none (6-6 ). Bnl's, SE. 
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Figure 4. Spread in g activity of va rious proteins in the prcsence ofTPA 
(10 ng/ ml), T he concentrat ions of BSA (e_e) and ova lbumin (x-x) werc 
II1creased from 0- 10 mg/ ml; the conccntration of the epibolin prcparation 
(0-0) was increased from 0-25 /-Lg/ l11l. Bars, SE, 
tein kinase C, it had no signi fica nt coep ibo lin ac ti vity. Three 
sepa rate prepa rations of OAG were tested from 2 sources (S ig m a 
C hem ica l Co. and A vant i Pol ar Lipids) ove r a broad concentration 
range in 2 solvents (ethano l, DMSO) and after soni cation . Despite 
these efforts, OAG had no effect. In contrast to OAG, the com-
plete phorbo l ester PDD and the non phorbol ester, mezerein (a 
second-stage tumor pro m oter w hi ch ca n also act iva te protein 
kinase C) [1 01 we re active, T he tu mor- promotin g propert ies of 
these substa nces appear to be important in that the a'-iso mer, 
4aPDD, a phorbol w ith no tum o r-prom otin g properties, is in-
Table I. Coepib'o lin Activ ity of Variou s C hemi ca ls in the 
Presence and Absence ofTPA 
Percent Cell Sprcadin g 
Chcmica l - T PA +TI'A 
No addition" 
Mczerein 
12 ::!: 2 (14) 69 ::!: 2 (12) 
l Oa ng/l11 l 66 ::!: 4 (8) 56 ::!: 2 (4) 
10 ng/ llli 74 ::!: 3 (8) 53 ::!: 4 (4) 
(41'1)1)) 4-Phorbo l- 12, 13-d ideca noate 
10 ng/ 1l11 46 ::!: 4 (6) 49 ::!: 4 (5) 
(4aPI)D) 4-a lpha-Pho rbol- 12, 13-d ideca noate 
100 ng/ l11l 16 ::!: 4 (13) 64 ::!: 2 (12) 
10 ng/ l11l 16 ::!: 4 (12) 61 ::!: 3 (12) 
(OAG) 1-0Icoyl-2-acety l-sn-glycerol 
4 /-Lg/ml 6 ::!: 2 (4) 58 ::!: 3 (4) 
IO/-Lg/ IllI 4 ::!: 2 (4) 35 ::!: 3 (4) 
20/-Lg/l11 l 1 ::!: I (4) 48 ::!: S (4) 
40 p.g/ l11l o ::!: 0 (4) 33 ::!: 5 (4) 
(I BMX) 3-lsobutyl- l- mcthyl xanthine 
22 /-L g/ ml 11 ::!: 2 (8) 55 ::!: 2 (10) 
2,2 p.g/ llli 13 ::!: 1 (8) 66 ::!: 2 (9) 
0.2 /-Lg/111 1 9 ::!: 2 (8) (,6 ::!: 2 (8) 
dIn :1 1\ assays the m edi u lll consisted o r DMEM pillS cpibolin prcp:1ratioll (1.25 
/-Lg/ ml). T he test med iulll was prepared w ith all additions befo re the ce ll s were 
:H.;d(.'d . The ex periment W:1.s stopped after 4-h in cuba tion. TPA , OAG, III czcrcin , 
41 DD, and 4aPDD we re d ilu ted fro m a stock solu tion in DMSO stored in the dark 
at - 14°C. The co ntro l co ntain ed th e ma xim al ( I 'Yo) concentra ti o n of DMSO used 
111 :lI1 y expe rim ent. 
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active in this syste m . Sin ce TPA has been repo rted to depress 
cA MP levels [11 ,12] and sin ce cAMP has been impli ca ted in the 
modul ation of epidermal cell spreadin g [1 3-16], we tested w hethe'r 
elevated cAMP levels mig ht antagoni ze the coep ibo lin effect of 
TPA. The phosphodiesterase inhibi tor, IBMX, over a w ide con-
centration ran ge (1-100 f.LM) did not have coepibolin activity and, 
moreove r, did not block the TPA effect . Thus, it is unlikely that 
the TPA effect is m ediated via cAMP. 
D ISC U SS IO N 
Ea rli er studies have shown that w hi le purifi ed epibolin alone sup-
ports cell spread in g in vitro, ma xima l spread in g (as compared 
w ith comp lete serum ) occurs on ly in the presence of a second 
plasma fraction referred to as coepibo lin [1 J. T he biochemica l 
mechani sm by w hich scrum-der ived coepibolin affects the spread-
in g ca pacity of ep ibolin is not clear. Coepibo lin act ivity is not 
co mm o n to all pro te ins ; its presen ce must be co ntinu o us to eli cit 
an effect (it does not act independently o n ep ibo lin , th e cell , or 
the substratum ) and it ca nnot repla ce the d ivalent cat io n content 
of the m edium (Core and Stenn , in preparation). T hat the pres-
ence of coepibo lin mi g ht be a req uirem ent of so m e cell ty pes and 
not of others cou ld exp lain its req uirem ent in thi s system in 
con trast to o ther cell system s w here epibo lin- like molecules have 
bee n used [5,7,8]. 
Recentl y , it has been demonstrated that the recepto r for phorbol 
d ies ter (TPA) associa tes with protein kinase C [1 7-19J. Physio-
logica ll y, it is genera lly held th at protein k in ase C is dircctly 
act ivated by d iacy lg lycero l w hi ch, in turn , is liberated after the 
ac tivation of membrane phosphatidy l in osito l. Purified protein 
kinase C has been shown to have a broad ran ge of substrate 
phosphorylatin g serine and threo nin e res idues of proteins in neu-
trophils [20], pituitary cells [21 [, platelets [221, and other ti ssues 
[1 9J. T hat OAG, a d iacy lg lycero l, does not reprod uce the phorbol 
effect in this system is dism ayin g. However, m ll cr workers [23,24] 
have also obser ved an absent OAG effect in studyin g w ho le cell 
sys tems w here a stron g ly positi ve TPA effect was fo un d . Ev i-
den ce that diacy lg lycero ls such as O AG are rapidly degraded 
(15-30 m in) in w hole cellu.la r systems has been presented [25]. 
Alth o ug h we used hi gh concentrations of O AG in these studies, 
it is pro bable that the end point we were m easurin g (spread of 
cytoplas m) is of such comp lex it y that it requires a lo ng- lived 
signal. In li ght of other studies (25), it is reasonab le to suppose 
that th e OAG results here are fal sely nega tive. 
Pho rbo l csters, such as T PA , have been shown not on ly to 
p ro m ote tumors in a 2-stage ca rcinogenes is anim al m odel but also 
to stimulate a num be r o f pleiotro pi c effects in many biologic 
syste m s 1261. Fo r so m e ce ll types the phorbo l es ters induce cell 
d iffe rentiatio n; for o th ers, they block sponta neo us o r induced 
diffe ren tiation. In the epidermal system, TPA is fo und to stim-
ulate the differentiation of so me epiderm al cells [27,28] and th e 
g rowth of others [29-31 [, a findin g w hi ch also undersco res the 
hete rogeneity of epidermal cell s. 
Alth o ug h the ev idence prescn ted in this paper is indirect, it is 
sugges tive that the coepibolin-epibo lin effect m ediates through 
protcin kinase C. D irect evidence testin g this co nclu sion is forth-
co min g. H ow cpibolin alone effects spreadin g is not su ggested 
by this work. T hat pro tein kinase C and the TP A effect have 
been found to inAuence o ther cytoskeleta l pheno m ena has been 
described 124,32-35'[ and m ay bear relevan ce to the spreadin g of 
ep ider m al cell s . 
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